December 27, 2016
Shire’s Adynovate cleared for young children haemaphilia patients
Shire will now be able to use its Adynovate for treating heamophilia A in children younger than 12 years of age, as the the U.S. Food and Drug Administration (FDA) has approved it for that age group. The FDA has also…